Ramaswamy Govindan, MD, and Yi-Long Wu, MD: Results From the CTONG ADJUVANT Trial

Posted: Monday, June 5, 2017

Ramaswamy Govindan, MD, of Washington University, and Yi-Long Wu, MD, of the Guangdong Lung Cancer Institute, discuss phase III study findings on gefitinib vs vinorelbine plus cisplatin as adjuvant treatment in stage II-IIIA (N1-N2) non–small-cell lung cancer with EGFR-activating mutation.